Revvity (formerly PerkinElmer)

Revvity (formerly PerkinElmer) is an American multinational life sciences and diagnostics company headquartered in Waltham, Massachusetts, United States. Rebranded in 2023 following the spin-off of its diagnostics business, it provides health science solutions luding reagents, instruments, and software for drug discovery and research. The company's segments lude Life Sciences (reagents and automation for pharma/biotech) and Discovery & Quantitation (analytical tools for genomics and proteomics). Revvity operates in over 100 countries with manufacturing in the U.S., Europe, and Asia, partnering with academic and corporate labs through global distribution. Its supply chain ludes third-party vendors for lab consumables and IT infrastructure, adhering to ISO 13485 for quality, GLP for research integrity, and GDPR for data privacy, with vendor risk management programs ensuring compliance in regulated environments like clinical trials. The firm focuses on sustainable practices, luding reduced plastic use in packaging. In fiscal year 2024, ending December 31, Revvity reported revenues of $2.84 billion, a 17% decrease from 2023 primarily due to COVID testing declines, offset by mid-single-digit growth in life sciences reagents.